Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,252 | 6,275 | -586 | -3,856 | -6,430 |
| Depreciation Amortization | -1,618 | -230 | 910 | 1,390 | 779 |
| Income taxes - deferred | 2,014 | 1,130 | 713 | 2,550 | 4,417 |
| Accounts receivable | 8,901 | -1,089 | 2,982 | 3,575 | 1,957 |
| Accounts payable and accrued liabilities | -10,791 | 11,793 | 15,070 | 13,732 | 13,426 |
| Other Working Capital | 22,040 | 6,074 | 7,423 | 64 | -50 |
| Other Operating Activity | 8,005 | 8,031 | -3,944 | -7,724 | -10,053 |
| Operating Cash Flow | $31,803 | $31,984 | $22,568 | $9,731 | $4,046 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -51 | -679 | -416 | -268 | -75 |
| Purchase Of Investment | -163,045 | -349,258 | -344,949 | -175,985 | -79,134 |
| Sale Of Investment | 350,390 | 399,862 | 319,862 | 172,527 | 90,075 |
| Investing Cash Flow | $187,294 | $49,925 | $-25,503 | $-3,726 | $10,866 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 734 | 129 | 125 | N/A |
| Financing Cash Flow | $N/A | $734 | $129 | $125 | $N/A |
| Exchange Rate Effect | 45 | 265 | 82 | 22 | -57 |
| Beginning Cash Position | 135,498 | 52,590 | 52,590 | 52,590 | 52,590 |
| End Cash Position | 354,640 | 135,498 | 49,866 | 58,742 | 67,445 |
| Net Cash Flow | $219,142 | $82,908 | $-2,724 | $6,152 | $14,855 |
| Free Cash Flow | |||||
| Operating Cash Flow | 31,803 | 31,984 | 22,568 | 9,731 | 4,046 |
| Capital Expenditure | -51 | -679 | -416 | -268 | -75 |
| Free Cash Flow | 31,752 | 31,305 | 22,152 | 9,463 | 3,971 |